Effectiveness of influenza vaccination against SARS-CoV-2 infection among healthcare workers in Qatar
- PMID: 36603377
- PMCID: PMC9791790
- DOI: 10.1016/j.jiph.2022.12.016
Effectiveness of influenza vaccination against SARS-CoV-2 infection among healthcare workers in Qatar
Abstract
Background: Some studies have reported that influenza vaccination is associated with lower risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and/or coronavirus disease 2019 (COVID-19) morbidity and mortality. This study aims to estimate effectiveness of influenza vaccination, using Abbott's quadrivalent Influvac Tetra vaccine, against SARS-CoV-2 infection and against severe COVID-19.
Methods: This matched, test-negative, case-control study was implemented on a population of 30,774 healthcare workers (HCWs) in Qatar during the 2020 annual influenza vaccination campaign, September 17, 2020-December 31, 2020, before introduction of COVID-19 vaccination.
Results: Of 30,774 HCWs, 576 with PCR-positive tests and 10,033 with exclusively PCR-negative tests were eligible for inclusion in the study. Matching by sex, age, nationality, reason for PCR testing, and PCR test date yielded 518 cases matched to 2058 controls. Median duration between influenza vaccination and the PCR test was 43 days (IQR, 29-62). Estimated effectiveness of influenza vaccination against SARS-CoV-2 infection> 14 days after receiving the vaccine was 29.7% (95% CI: 5.5-47.7%). Estimated effectiveness of influenza vaccination against severe, critical, or fatal COVID-19 was 88.9% (95% CI: 4.1-98.7%). Sensitivity analyses confirmed the main analysis results.
Conclusions: Recent influenza vaccination is associated with a significant reduction in the risk of SARS-CoV-2 infection and COVID-19 severity.
Keywords: COVID-19; Case-control; Epidemiology; Immunity; Influenza; Vaccine.
Copyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Conflict of interest The authors declare no conflict of interest.
Figures
Similar articles
-
Safety profile and SARS-CoV-2 breakthrough infections among HCWs receiving anti-SARS-CoV-2 and influenza vaccines simultaneously: an Italian observational study.Vaccine. 2023 Aug 31;41(38):5655-5661. doi: 10.1016/j.vaccine.2023.07.043. Epub 2023 Aug 4. Vaccine. 2023. PMID: 37544827
-
Risk factors for breakthrough SARS-CoV-2 infection in vaccinated healthcare workers.PLoS One. 2021 Oct 15;16(10):e0258820. doi: 10.1371/journal.pone.0258820. eCollection 2021. PLoS One. 2021. PMID: 34653228 Free PMC article.
-
Effectiveness of BNT162b2 mRNA Coronavirus Disease 2019 (COVID-19) Vaccine Against Acquisition of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Among Healthcare Workers in Long-Term Care Facilities: A Prospective Cohort Study.Clin Infect Dis. 2022 Aug 24;75(1):e755-e763. doi: 10.1093/cid/ciab918. Clin Infect Dis. 2022. PMID: 34698808 Free PMC article.
-
Effectiveness of Whole-Virus COVID-19 Vaccine among Healthcare Personnel, Lima, Peru.Emerg Infect Dis. 2022 Dec;28(13):S238-S243. doi: 10.3201/eid2813.212477. Emerg Infect Dis. 2022. PMID: 36502444 Free PMC article. Review.
-
Evaluation of mortality attributable to SARS-CoV-2 vaccine administration using national level data from Qatar.Nat Commun. 2023 Jan 3;14(1):24. doi: 10.1038/s41467-022-35653-z. Nat Commun. 2023. PMID: 36596793 Free PMC article. Review.
Cited by
-
Inactivated Poliovirus Vaccine Booster Reduces the Likelihood of COVID-19 Outcomes in Individuals Primed with Oral Poliovirus Vaccination.Vaccines (Basel). 2024 Feb 20;12(3):219. doi: 10.3390/vaccines12030219. Vaccines (Basel). 2024. PMID: 38543853 Free PMC article.
-
Vaccination against influenza viruses reduces infection, not hospitalization or death, from respiratory COVID-19: A systematic review and meta-analysis.J Med Virol. 2024 Jan;96(1):e29343. doi: 10.1002/jmv.29343. J Med Virol. 2024. PMID: 38163281
-
Seroprevalence of SARS-CoV-2 antibodies among healthcare workers in Dutch hospitals after the 2020 first wave: a multicentre cross-sectional study with prospective follow-up.Antimicrob Resist Infect Control. 2023 Nov 29;12(1):137. doi: 10.1186/s13756-023-01324-x. Antimicrob Resist Infect Control. 2023. PMID: 38031155 Free PMC article.
-
A cross-sectional study from Qatar on the effect of influenza vaccination on the severity of COVID-19.Medicine (Baltimore). 2023 Sep 15;102(37):e35107. doi: 10.1097/MD.0000000000035107. Medicine (Baltimore). 2023. PMID: 37713897 Free PMC article.
-
A SARS-CoV-2 and influenza double hit vaccine based on RBD-conjugated inactivated influenza A virus.Sci Adv. 2023 Jun 23;9(25):eabo4100. doi: 10.1126/sciadv.abo4100. Epub 2023 Jun 23. Sci Adv. 2023. PMID: 37352360 Free PMC article.
References
-
- Pearson M.L., Bridges C.B., Harper S.A. Healthcare infection control practices advisory C, advisory committee on immunization P. Influenza vaccination of health-care personnel: recommendations of the healthcare infection control practices advisory committee (HICPAC) and the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm Rep. 2006;55(RR-2):1–16. PubMed PMID: 16498385. Epub 2006/02/25. - PubMed
-
- Fink G., Orlova-Fink N., Schindler T., Grisi S., Ferrer A.P.S., Daubenberger C., et al. Inactivated trivalent influenza vaccination is associated with lower mortality among patients with COVID-19 in Brazil. BMJ Evid Based Med. 2020 PubMed PMID: 33310766. Pubmed Central PMCID: PMC7735072. Epub 2020/12/15. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
